Skip to main content

Tafasitamab Dosage

Medically reviewed by Drugs.com. Last updated on Sep 16, 2024.

Applies to the following strengths: 200 mg

Usual Adult Dose for Lymphoma

12 mg/kg IV (based on actual body weight; Administer in combination with lenalidomide 25 mg orally for a maximum of 12 cycles, then continue this drug as monotherapy until disease progression or unacceptable toxicity:
CYCLE 1: 12 mg/kg IV on Days 1, 4, 8, 15, and 22
CYCLE 2: 12 mg/kg IV on Days 1, 8, 15, and 22
CYCLE 3: 12 mg/kg IV on Days 1 and 15


Comments:

Use: This drug in combination with lenalidomide, is indicated for the treatment of adult patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) not otherwise specified, including DLBCL arising from low grade lymphoma, and who are not eligible for autologous stem cell transplant (ASCT)

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments

DOSE MODIFICATIONS FOR ADVERSE REACTIONS:
INFUSION RELATED REACTIONS (IRRS):

MYELOSUPPRESSION:

Precautions

CONTRAINDICATIONS:


Safety and efficacy have not been established in patients younger than 18 years.

Consult WARNINGS section for additional precautions.

Dialysis

Data not available

Other Comments

Administration advice:


Storage requirements:

Reconstitution/preparation techniques:

IV compatibility:

General:

Frequently asked questions

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.